We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
Cap. Flow
-$438M
Cap. Flow %
-78.37%
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.5M
2
C icon
Citigroup
C
+$10.5M
3
MSFT icon
Microsoft
MSFT
+$9.87M
4
OPTU
Optimum Communications Inc
OPTU
+$9.41M
5
AES icon
AES
AES
+$7.92M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 17.95%
3 Healthcare 12.14%
4 Communication Services 8.7%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRL icon
101
Hormel Foods
HRL
$13.9B
$1.73M 0.31%
35,490
+19,629
+124% +$861K
MP icon
102
MP Materials
MP
$8.53B
$1.71M 0.31%
+37,640
New +$1.48M
PACB icon
103
Pacific Biosciences
PACB
$404M
$1.71M 0.31%
+83,489
New +$2.01M
EMR icon
104
Emerson Electric
EMR
$91B
$1.7M 0.3%
+18,276
New +$1.72M
HAPN
105
Happen Inc
HAPN
$2.36B
$1.68M 0.3%
69,521
-12,451
-15% -$422K
DQ
106
Daqo New Energy
DQ
$899M
$1.67M 0.3%
+41,428
New +$2.41M
GS icon
107
Goldman Sachs
GS
$313B
$1.67M 0.3%
+4,360
New +$1.73M
AMRS
108
DELISTED
Amyris Inc.
AMRS
$1.64M 0.29%
302,921
+258,540
+583% +$2.41M
SFIX
109
Stitch Fix
SFIX
$550M
$1.6M 0.29%
84,527
-47,051
-36% -$1.35M
ELAN icon
110
Elanco Animal Health
ELAN
$13.1B
$1.59M 0.28%
+55,985
New +$1.74M
CAN
111
Canaan Creative
CAN
$147M
$1.55M 0.28%
301,807
+26,590
+10% +$200K
RVLV icon
112
Revolve Group
RVLV
$1.81B
$1.55M 0.28%
+27,710
New +$1.95M
WYNN icon
113
Wynn Resorts
WYNN
$10.5B
$1.54M 0.28%
+18,118
New +$1.6M
AAL icon
114
American Airlines Group
AAL
$11B
$1.51M 0.27%
+84,072
New +$1.61M
KDP icon
115
Keurig Dr Pepper
KDP
$41.8B
$1.49M 0.27%
40,513
-52,884
-57% -$1.87M
XM
116
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$1.49M 0.27%
+42,167
New +$1.64M
HOOD icon
117
Robinhood
HOOD
$83.4B
$1.47M 0.26%
+82,556
New +$2.54M
GTM
118
ZoomInfo Technologies
GTM
$1.08B
$1.45M 0.26%
22,644
-44,103
-66% -$2.95M
FUBO icon
119
FuboTV Inc
FUBO
$314M
$1.45M 0.26%
+7,798
New +$2.19M
BRKR icon
120
Bruker
BRKR
$7.99B
$1.45M 0.26%
17,250
+13,016
+307% +$1.04M
HMC icon
121
Honda
HMC
$39.7B
$1.44M 0.26%
+50,472
New +$1.47M
BE icon
122
Bloom Energy
BE
$69B
$1.43M 0.26%
64,989
+23,623
+57% +$598K
CALY
123
Callaway Golf Company
CALY
$3.44B
$1.41M 0.25%
+51,233
New +$1.42M
DNMR
124
DELISTED
Danimer Scientific, Inc.
DNMR
$1.4M 0.25%
4,103
-101
-2% -$55.6K
PAAS icon
125
Pan American Silver
PAAS
$20.3B
$1.39M 0.25%
55,791
+15,497
+38% +$390K

Similar funds

Seven Eight Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.

  • Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
  • Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
  • Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
  • Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
  • Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
  • Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
  • Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.